Zai Lab (ZLAB) Interest & Investment Income (2020 - 2026)
Zai Lab's (ZLAB) quarterly Interest & Investment Income came in at $6.4 million in Q1 2026, down 25.09% year-on-year from $8.6 million in Q1 2025, and down 11.12% quarter-over-quarter from $7.3 million in Q4 2025.
Zai Lab (ZLAB) Interest & Investment Income (2020 - 2026) Analysis & Trends
Zai Lab has disclosed Interest & Investment Income across 7 years of filings, most recently posting $6.4 million for Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $6.4 million, down 25.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $30.9 million (down 14.32% YoY), and the FY2025 annual result was $33.0 million, down 10.93% from the prior year.
- Interest & Investment Income came in at $6.4 million for Q1 2026 at Zai Lab, down from $7.3 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $10.3 million in Q4 2023 to a low of $188000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $9.0 million (2024), against an average of $7.7 million.
- Across the five-year window, Interest & Investment Income soared 5342.55% in 2023 and decreased 25.09% in 2026, its largest moves.
- Zai Lab's Interest & Investment Income stood at $9.3 million in 2022, then grew by 10.24% to $10.3 million in 2023, then slipped by 11.8% to $9.1 million in 2024, then retreated by 20.18% to $7.3 million in 2025, then slipped by 11.12% to $6.4 million in 2026.
- The last three Interest & Investment Income figures came in at $6.4 million (Q1 2026), $7.3 million (Q4 2025), and $8.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | 6.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.45 Mn |
| Dec 31, 2025 | 7.25 Mn |
| Sep 30, 2025 | 8.35 Mn |
| Jun 30, 2025 | 8.84 Mn |
| Mar 31, 2025 | 8.61 Mn |
| Dec 31, 2024 | 9.09 Mn |
| Sep 30, 2024 | 9.03 Mn |
| Jun 30, 2024 | 9.33 Mn |
| Mar 31, 2024 | 9.66 Mn |
| Dec 31, 2023 | 10.30 Mn |
| Sep 30, 2023 | 9.17 Mn |
| Jun 30, 2023 | 10.09 Mn |
| Mar 31, 2023 | 10.23 Mn |
| Dec 31, 2022 | 9.35 Mn |
| Sep 30, 2022 | 3.87 Mn |
| Jun 30, 2022 | 1.18 Mn |
| Mar 31, 2022 | 188,000.00 |
| Dec 31, 2021 | 1.02 Mn |
| Sep 30, 2021 | 713,000.00 |
| Jun 30, 2021 | 244,000.00 |